Single dose varenicline may trigger epileptic activity
Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of varenicline cause epileptic activity. Forty rats were randomly assigned to the following eight groups: control, saline, and 0.025, 0.04, 0.1,...
Saved in:
Published in: | Neurological sciences Vol. 35; no. 11; pp. 1807 - 1812 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Milan
Springer Milan
01-11-2014
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of varenicline cause epileptic activity. Forty rats were randomly assigned to the following eight groups: control, saline, and 0.025, 0.04, 0.1, 0.5, 1, and 2 mg kg
−1
varenicline (single dose, i.p.). EEGs were recorded before the varenicline injection and during the following 240 min. While epileptic discharges were observed on the EEGs of the rats in all of the varenicline-treated groups, motor findings of epileptic seizure were not observed in some rats in these groups except the 1 and 2 mg kg
−1
groups. These findings indicate that different single doses of varenicline cause epileptic activity in rats. |
---|---|
AbstractList | Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of varenicline cause epileptic activity. Forty rats were randomly assigned to the following eight groups: control, saline, and 0.025, 0.04, 0.1, 0.5, 1, and 2 mg kg(-1) varenicline (single dose, i.p.). EEGs were recorded before the varenicline injection and during the following 240 min. While epileptic discharges were observed on the EEGs of the rats in all of the varenicline-treated groups, motor findings of epileptic seizure were not observed in some rats in these groups except the 1 and 2 mg kg(-1) groups. These findings indicate that different single doses of varenicline cause epileptic activity in rats. Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of varenicline cause epileptic activity. Forty rats were randomly assigned to the following eight groups: control, saline, and 0.025, 0.04, 0.1, 0.5, 1, and 2 mg kg^sup -1^ varenicline (single dose, i.p.). EEGs were recorded before the varenicline injection and during the following 240 min. While epileptic discharges were observed on the EEGs of the rats in all of the varenicline-treated groups, motor findings of epileptic seizure were not observed in some rats in these groups except the 1 and 2 mg kg^sup -1^ groups. These findings indicate that different single doses of varenicline cause epileptic activity in rats.[PUBLICATION ABSTRACT] Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of varenicline cause epileptic activity. Forty rats were randomly assigned to the following eight groups: control, saline, and 0.025, 0.04, 0.1, 0.5, 1, and 2 mg kg −1 varenicline (single dose, i.p.). EEGs were recorded before the varenicline injection and during the following 240 min. While epileptic discharges were observed on the EEGs of the rats in all of the varenicline-treated groups, motor findings of epileptic seizure were not observed in some rats in these groups except the 1 and 2 mg kg −1 groups. These findings indicate that different single doses of varenicline cause epileptic activity in rats. Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of varenicline cause epileptic activity. Forty rats were randomly assigned to the following eight groups: control, saline, and 0.025, 0.04, 0.1, 0.5, 1, and 2 mg kg super(-1) varenicline (single dose, i.p.). EEGs were recorded before the varenicline injection and during the following 240 min. While epileptic discharges were observed on the EEGs of the rats in all of the varenicline-treated groups, motor findings of epileptic seizure were not observed in some rats in these groups except the 1 and 2 mg kg super(-1) groups. These findings indicate that different single doses of varenicline cause epileptic activity in rats. |
Author | Erken, Haydar Ali Şimşek, Hasan Yavuz, Özlem Genç, Osman Korkut, Oğuzhan Erken, Gülten Koç, Emine Rabia |
Author_xml | – sequence: 1 givenname: Haydar Ali surname: Erken fullname: Erken, Haydar Ali email: haerken@yahoo.com organization: Department of Physiology, Faculty of Medicine, Balikesir University – sequence: 2 givenname: Gülten surname: Erken fullname: Erken, Gülten organization: Department of Physiology, Faculty of Medicine, Balikesir University – sequence: 3 givenname: Hasan surname: Şimşek fullname: Şimşek, Hasan organization: Department of Physiology, Faculty of Medicine, Dumlupinar University – sequence: 4 givenname: Oğuzhan surname: Korkut fullname: Korkut, Oğuzhan organization: Department of Pharmacology, Faculty of Medicine, Balikesir University – sequence: 5 givenname: Emine Rabia surname: Koç fullname: Koç, Emine Rabia organization: Department of Neurology, Faculty of Medicine, Balikesir University – sequence: 6 givenname: Özlem surname: Yavuz fullname: Yavuz, Özlem organization: Department of Biochemistry, Faculty of Medicine, Balikesir University – sequence: 7 givenname: Osman surname: Genç fullname: Genç, Osman organization: Department of Physiology, Faculty of Medicine, Dumlupinar University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24906297$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kMtKxDAUhoOMOBd9ADdScOOmmtOmTbOUwRsMuFDXIU1Phwy9mbQDfXszdBQR3CSBfP9_Dt-SzJq2QUIugd4CpfzOHc4opMBCyFgSjidkAYmgYcx4Nju-IeNsTpbO7Sj1JMRnZB4xQdNI8AVJ30yzrTAoWofBXllsjK5Mg0GtxqC3ZrtFG2BnKux6owOle7M3_XhOTktVObw43ivy8fjwvn4ON69PL-v7TagTBn2YxzFgzNOMKVrmAuMoRQ6Ma64UK4skKXSWxDQXIBSkUKLSZZQLgZonIvH8itxMvZ1tPwd0vayN01hVqsF2cBLSiIuMAzCPXv9Bd-1gG7-dp0BAmqUs9hRMlLatcxZL2VlTKztKoPKgU05SpVclD1Ll6DNXx-Yhr7H4SXxb9EA0Ac5_Nd7Yr9H_tn4BvfODDA |
CitedBy_id | crossref_primary_10_1016_j_yebeh_2019_05_031 crossref_primary_10_3389_fmolb_2022_860246 crossref_primary_10_1038_s41598_022_05697_8 crossref_primary_10_3390_ijms24032616 |
Cites_doi | 10.1016/0091-3057(86)90476-4 10.1038/nrn731 10.2174/1568026043451447 10.1124/mol.106.025130 10.1016/j.eplepsyres.2011.06.006 10.1136/bmj.c6549 10.1038/nrn2635 10.1002/cne.903630212 10.1093/ntr/ntr213 10.1124/dmd.105.006767 10.1523/JNEUROSCI.3009-04.2004 10.1016/S0306-4522(02)00371-8 10.1016/j.neuropharm.2007.01.006 10.1177/0091270010372388 10.1002/syn.21655 10.1002/hipo.1060 10.1016/S0928-4257(98)80013-2 10.1124/jpet.113.206904 10.1007/s00213-013-3340-1 10.1016/j.neuint.2010.06.005 10.1111/ijcp.12121 10.1016/S0079-6123(03)45007-3 10.1093/cercor/bhh052 10.1007/BF02740649 10.1038/nrd2088 10.2165/11319180-000000000-00000 10.1016/S1734-1140(13)70978-2 10.1016/j.bcp.2009.05.024 10.1111/j.1528-1157.2000.tb00300.x 10.1016/j.neuropharm.2009.04.006 10.1159/000118966 10.1177/0091270006290669 10.1016/j.neuropharm.2008.08.025 10.1016/j.lfs.2012.12.013 10.1684/epd.2010.0339 10.1523/JNEUROSCI.13-06-02680.1993 10.1152/jn.1994.72.3.1317 |
ContentType | Journal Article |
Copyright | Springer-Verlag Italia 2014 |
Copyright_xml | – notice: Springer-Verlag Italia 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9- K9. M0R M0S M1P M2M PQEST PQQKQ PQUKI PRINS PSYQQ Q9U |
DOI | 10.1007/s10072-014-1845-y |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE ProQuest One Psychology Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1590-3478 |
EndPage | 1812 |
ExternalDocumentID | 3478298421 10_1007_s10072_014_1845_y 24906297 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0VY 123 199 1N0 2.D 203 29N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDBF ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACSNA ACTTH ACUDM ACVWB ACWMK ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADPHR ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN AZQEC B-. B0M BA0 BDATZ BENPR BGNMA BKNYI BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EAD EAP EAS EBC EBD EBLON EBS EBX ECV EHN EIOEI EJD EMB EMK EMOBN EN4 ENC ENX EPAXT EPL EPS EPT ESBYG ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KPH LAS LLZTM M0R M1P M2M M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOR QOS Q~Q R89 R9I RIG ROL RPX RRX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC TUS U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7W Z7X Z81 Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~8M ~A9 0R~ AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7TK 7XB 8FK K9. PQEST PQUKI PRINS Q9U |
ID | FETCH-LOGICAL-c541t-b331e37684a0fb9e326e7147c7aa4fd55dc8530b919a161feacf2b99ec75959e3 |
IEDL.DBID | AEJHL |
ISSN | 1590-1874 |
IngestDate | Fri Oct 25 06:52:54 EDT 2024 Tue Nov 19 04:35:51 EST 2024 Thu Nov 21 23:00:02 EST 2024 Tue Oct 15 23:55:25 EDT 2024 Sat Dec 16 12:04:59 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Seizure Adverse effect EEG Epilepsy Varenicline |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-b331e37684a0fb9e326e7147c7aa4fd55dc8530b919a161feacf2b99ec75959e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24906297 |
PQID | 1619168643 |
PQPubID | 27321 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1627987114 proquest_journals_1619168643 crossref_primary_10_1007_s10072_014_1845_y pubmed_primary_24906297 springer_journals_10_1007_s10072_014_1845_y |
PublicationCentury | 2000 |
PublicationDate | 2014-11-01 |
PublicationDateYYYYMMDD | 2014-11-01 |
PublicationDate_xml | – month: 11 year: 2014 text: 2014-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Milan |
PublicationPlace_xml | – name: Milan – name: Italy – name: Milano |
PublicationSubtitle | Official Journal of the Italian Neurological Society |
PublicationTitle | Neurological sciences |
PublicationTitleAbbrev | Neurol Sci |
PublicationTitleAlternate | Neurol Sci |
PublicationYear | 2014 |
Publisher | Springer Milan Springer Nature B.V |
Publisher_xml | – name: Springer Milan – name: Springer Nature B.V |
References | Levin, Weaver, Palmatier, Caggiula, Sved, Donny (CR22) 2012; 14 Hussy, Ballivet, Bertrand (CR32) 1994; 72 Spiller, Xi, Li (CR21) 2009; 57 CR19 Beleslin, Krstić (CR30) 1986; 24 Cahill, Stead, Lancaster (CR2) 2008; 16 Mineur, Somenzi, Picciotto (CR33) 2007; 52 Mihalak, Carroll, Luetje (CR3) 2006; 70 Serafini, Crespel, Velizara, Gelisse (CR20) 2010; 12 Léna, Changeux, Mulle (CR10) 1993; 13 Decker, Rueter, Bitner (CR14) 2004; 4 Aracri, Amadeo, Pasini, Fascio, Becchetti (CR12) 2013; 67 Descarries (CR8) 1998; 92 André, Marescaux, Nehlig, Fritschy (CR27) 2001; 11 Alkondon, Albuquerque (CR5) 2004; 145 Jones, Wonnacott (CR9) 2004; 24 Peng, Stokes, Mineur (CR34) 2013; 347 Dani (CR13) 2000; 41 Fagerstrom, Gilljam, Metcalfe, Tonstad, Messig (CR17) 2010; 341 Feuerbach, Lingenhoehl, Olpe (CR35) 2009; 56 Karlin (CR23) 2002; 3 Ween, Thorin-Hagene, Andersen (CR25) 2010; 57 Rathouz, Vijayaraghavan, Berg (CR24) 1996; 12 Speckmann, Straub, Köhling (CR26) 1993; 27 DuBois, Damborsky, Fincher, Frye, Winzer-Serhan (CR29) 2013; 92 Tonstad, Davies, Flammer, Russ, Hughes (CR18) 2010; 33 Sarter, Parikh, Howe (CR4) 2009; 10 Gotti, Clementi, Fornari (CR6) 2009; 78 Wang, Cho, Xiao, Wajsbrot, Park (CR36) 2013; 67 Niaura, Jones, Kirkpatrick (CR1) 2006; 5 Bina, Guzman, Broide, Leslie, Smith, O’Dowd (CR7) 1995; 363 Kikkawa, Maruyama, Fujimoto, Hasunuma (CR39) 2011; 51 Tutka, Mróz, Bednarski (CR31) 2013; 65 Sitges, Sanchez-Tafolla, Chiu, Aldana, Guarneros (CR28) 2011; 96 Obach, Reed-Hagen, Krueger (CR38) 2006; 34 Zhu, Chiappinelli (CR11) 2002; 115 Braida, Ponzoni, Martucci, Sparatore, Gotti, Sala (CR16) 2014; 231 Dalley, Theobald, Bouger, Chudasama, Cardinal, Robbins (CR15) 2004; 14 Faessel, Smith, Gibbs, Gobey, Clark, Burstein (CR37) 2006; 46 16883648 - Nat Rev Drug Discov. 2006 Jul;5(7):537-8 23574106 - Int J Clin Pract. 2013 May;67(5):469-76 20551220 - J Clin Pharmacol. 2011 Apr;51(4):527-37 23424068 - Synapse. 2013 Jun;67(6):338-57 20297861 - Drug Saf. 2010 Apr 1;33(4):289-301 8818146 - Mol Neurobiol. 1996 Apr;12(2):117-31 21287775 - Epileptic Disord. 2010 Dec;12(4):338 23563038 - Pharmacol Rep. 2013;65(1):195-200 18646137 - Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103 24311357 - Psychopharmacology (Berl). 2014 May;231(9):1975-85 8642078 - J Comp Neurol. 1995 Dec 11;363(2):321-32 2874565 - Pharmacol Biochem Behav. 1986 Jun;24(6):1509-11 23352971 - Life Sci. 2013 Mar 14;92(6-7):337-44 15084496 - Cereb Cortex. 2004 Aug;14(8):922-32 19377503 - Nat Rev Neurosci. 2009 May;10 (5):383-90 19393252 - Neuropharmacology. 2009 Jul;57(1):60-6 21134997 - BMJ. 2010 Dec 06;341:c6549 10961642 - Epilepsia. 2000 Aug;41(8):1063-5 8501532 - J Neurosci. 1993 Jun;13(6):2680-8 18793655 - Neuropharmacology. 2009 Jan;56(1):254-63 20558224 - Neurochem Int. 2010 Oct;57(3):269-77 9789811 - J Physiol Paris. 1998 Jun-Aug;92(3-4):215-20 17320916 - Neuropharmacology. 2007 Apr;52(5):1256-62 14650910 - Prog Brain Res. 2004;145:109-20 7807214 - J Neurophysiol. 1994 Sep;72(3):1317-26 15601930 - J Neurosci. 2004 Dec 15;24(50):11244-52 19481063 - Biochem Pharmacol. 2009 Oct 1;78(7):703-11 23959137 - J Pharmacol Exp Ther. 2013 Nov;347(2):424-37 16920893 - J Clin Pharmacol. 2006 Sep;46(9):991-8 11836518 - Nat Rev Neurosci. 2002 Feb;3(2):102-14 11530850 - Hippocampus. 2001;11(4):452-68 21994342 - Nicotine Tob Res. 2012 Mar;14(3):299-305 12401328 - Neuroscience. 2002;115(1):137-44 16221753 - Drug Metab Dispos. 2006 Jan;34(1):121-30 14754452 - Curr Top Med Chem. 2004;4(3):369-84 8232825 - Neuropsychobiology. 1993;27(3):122-6 21737246 - Epilepsy Res. 2011 Oct;96(3):257-66 16766716 - Mol Pharmacol. 2006 Sep;70(3):801-5 PJ Zhu (1845_CR11) 2002; 115 S Tonstad (1845_CR18) 2010; 33 K Fagerstrom (1845_CR17) 2010; 341 EJ Speckmann (1845_CR26) 1993; 27 C Peng (1845_CR34) 2013; 347 P Aracri (1845_CR12) 2013; 67 D Feuerbach (1845_CR35) 2009; 56 KB Mihalak (1845_CR3) 2006; 70 JA Dani (1845_CR13) 2000; 41 H Ween (1845_CR25) 2010; 57 YS Mineur (1845_CR33) 2007; 52 MM Rathouz (1845_CR24) 1996; 12 JW Dalley (1845_CR15) 2004; 14 ME Levin (1845_CR22) 2012; 14 M Sitges (1845_CR28) 2011; 96 IW Jones (1845_CR9) 2004; 24 DW DuBois (1845_CR29) 2013; 92 A Serafini (1845_CR20) 2010; 12 L Descarries (1845_CR8) 1998; 92 C Léna (1845_CR10) 1993; 13 H Kikkawa (1845_CR39) 2011; 51 1845_CR19 RS Obach (1845_CR38) 2006; 34 R Niaura (1845_CR1) 2006; 5 C Wang (1845_CR36) 2013; 67 M Alkondon (1845_CR5) 2004; 145 A Karlin (1845_CR23) 2002; 3 P Tutka (1845_CR31) 2013; 65 M Sarter (1845_CR4) 2009; 10 MW Decker (1845_CR14) 2004; 4 D Braida (1845_CR16) 2014; 231 KG Bina (1845_CR7) 1995; 363 C Gotti (1845_CR6) 2009; 78 K Spiller (1845_CR21) 2009; 57 V André (1845_CR27) 2001; 11 DB Beleslin (1845_CR30) 1986; 24 N Hussy (1845_CR32) 1994; 72 HM Faessel (1845_CR37) 2006; 46 K Cahill (1845_CR2) 2008; 16 |
References_xml | – volume: 24 start-page: 1509 year: 1986 end-page: 1511 ident: CR30 article-title: Nicotine-induced convulsions in cats and central nicotinic receptors publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(86)90476-4 contributor: fullname: Krstić – volume: 3 start-page: 102 year: 2002 end-page: 114 ident: CR23 article-title: Emerging structure of the nicotinic acetylcholine receptors publication-title: Nat Rev Neurosci doi: 10.1038/nrn731 contributor: fullname: Karlin – volume: 4 start-page: 369 year: 2004 end-page: 384 ident: CR14 article-title: Nicotinic acetylcholine receptor agonists: a potential new class of analgesics publication-title: Curr Top Med Chem doi: 10.2174/1568026043451447 contributor: fullname: Bitner – volume: 70 start-page: 801 year: 2006 end-page: 805 ident: CR3 article-title: Varenicline is a partial agonist at α β and a full agonist at α neuronal nicotinic receptors publication-title: Mol Pharmacol doi: 10.1124/mol.106.025130 contributor: fullname: Luetje – volume: 96 start-page: 257 year: 2011 end-page: 266 ident: CR28 article-title: Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2011.06.006 contributor: fullname: Guarneros – volume: 341 start-page: c6549 year: 2010 ident: CR17 article-title: Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial publication-title: BMJ doi: 10.1136/bmj.c6549 contributor: fullname: Messig – volume: 72 start-page: 1317 year: 1994 end-page: 1326 ident: CR32 article-title: Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by alpha and beta subunits publication-title: J Neurophysiol contributor: fullname: Bertrand – volume: 16 start-page: CD006103 year: 2008 ident: CR2 article-title: Nicotine receptor partial agonists for smoking cessation publication-title: Cochrane Database Syst Rev contributor: fullname: Lancaster – volume: 10 start-page: 383 year: 2009 end-page: 390 ident: CR4 article-title: Phasic acetylcholine release and the volume transmission hypothesis: time to move on publication-title: Nat Rev Neurosci doi: 10.1038/nrn2635 contributor: fullname: Howe – volume: 363 start-page: 321 year: 1995 end-page: 332 ident: CR7 article-title: Localization of alpha 7 nicotinic receptor subunit mRNA and alpha-bungarotoxin binding sites in developing mouse somatosensory thalamocortical system publication-title: J Comp Neurol doi: 10.1002/cne.903630212 contributor: fullname: O’Dowd – volume: 14 start-page: 299 year: 2012 end-page: 305 ident: CR22 article-title: Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntr213 contributor: fullname: Donny – volume: 34 start-page: 121 year: 2006 end-page: 130 ident: CR38 article-title: Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro publication-title: Drug Metab Dispos doi: 10.1124/dmd.105.006767 contributor: fullname: Krueger – volume: 24 start-page: 11244 year: 2004 end-page: 11252 ident: CR9 article-title: Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3009-04.2004 contributor: fullname: Wonnacott – volume: 115 start-page: 137 year: 2002 end-page: 144 ident: CR11 article-title: Nicotinic receptors mediate increased GABA release in brain through a tetrodotoxin-insensitive mechanism during prolonged exposure to nicotine publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00371-8 contributor: fullname: Chiappinelli – volume: 52 start-page: 1256 year: 2007 end-page: 1262 ident: CR33 article-title: Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2007.01.006 contributor: fullname: Picciotto – volume: 51 start-page: 527 year: 2011 end-page: 537 ident: CR39 article-title: Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers publication-title: J Clin Pharmacol doi: 10.1177/0091270010372388 contributor: fullname: Hasunuma – volume: 67 start-page: 338 year: 2013 end-page: 357 ident: CR12 article-title: Regulation of glutamate release by heteromeric nicotinic receptors in layer V of the secondary motor region (Fr2) in the dorsomedial shoulder of prefrontal cortex in mouse publication-title: Synapse doi: 10.1002/syn.21655 contributor: fullname: Becchetti – volume: 11 start-page: 452 year: 2001 end-page: 468 ident: CR27 article-title: Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium–pilocarpine model of temporal lobe epilepsy publication-title: Hippocampus doi: 10.1002/hipo.1060 contributor: fullname: Fritschy – volume: 92 start-page: 215 year: 1998 end-page: 220 ident: CR8 article-title: The hypothesis of an ambient level of acetylcholine in the central nervous system publication-title: J Physiol Paris doi: 10.1016/S0928-4257(98)80013-2 contributor: fullname: Descarries – volume: 347 start-page: 424 year: 2013 end-page: 437 ident: CR34 article-title: Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.113.206904 contributor: fullname: Mineur – volume: 13 start-page: 2680 year: 1993 end-page: 2688 ident: CR10 article-title: Evidence for “preterminal” nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus publication-title: J Neurosci contributor: fullname: Mulle – volume: 231 start-page: 1975 year: 2014 end-page: 1985 ident: CR16 article-title: Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish publication-title: Psychopharmacology doi: 10.1007/s00213-013-3340-1 contributor: fullname: Sala – volume: 57 start-page: 269 year: 2010 end-page: 277 ident: CR25 article-title: Alpha3* and alpha 7 nAChR-mediated Ca transient generation in IMR-32 neuroblastoma cells publication-title: Neurochem Int doi: 10.1016/j.neuint.2010.06.005 contributor: fullname: Andersen – ident: CR19 – volume: 67 start-page: 469 year: 2013 end-page: 476 ident: CR36 article-title: Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice publication-title: Int J Clin Pract doi: 10.1111/ijcp.12121 contributor: fullname: Park – volume: 145 start-page: 109 year: 2004 end-page: 120 ident: CR5 article-title: The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex publication-title: Prog Brain Res doi: 10.1016/S0079-6123(03)45007-3 contributor: fullname: Albuquerque – volume: 14 start-page: 922 year: 2004 end-page: 932 ident: CR15 article-title: Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex publication-title: Cereb Cortex doi: 10.1093/cercor/bhh052 contributor: fullname: Robbins – volume: 12 start-page: 117 year: 1996 end-page: 131 ident: CR24 article-title: Elevation of intracellular calcium levels in neurons by nicotinic acetylcholine receptors publication-title: Mol Neurobiol doi: 10.1007/BF02740649 contributor: fullname: Berg – volume: 5 start-page: 537 year: 2006 end-page: 538 ident: CR1 article-title: Varenicline publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2088 contributor: fullname: Kirkpatrick – volume: 33 start-page: 289 year: 2010 end-page: 301 ident: CR18 article-title: Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis publication-title: Drug Saf doi: 10.2165/11319180-000000000-00000 contributor: fullname: Hughes – volume: 65 start-page: 195 year: 2013 end-page: 200 ident: CR31 article-title: Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice publication-title: Pharmacol Rep doi: 10.1016/S1734-1140(13)70978-2 contributor: fullname: Bednarski – volume: 78 start-page: 703 year: 2009 end-page: 711 ident: CR6 article-title: Structural and functional diversity of native brain neuronal nicotinic receptors publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2009.05.024 contributor: fullname: Fornari – volume: 41 start-page: 1063 year: 2000 end-page: 1065 ident: CR13 article-title: Properties underlying the influence of nicotinic receptors on neuronal excitability and epilepsy publication-title: Epilepsia doi: 10.1111/j.1528-1157.2000.tb00300.x contributor: fullname: Dani – volume: 57 start-page: 60 year: 2009 end-page: 66 ident: CR21 article-title: Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.04.006 contributor: fullname: Li – volume: 27 start-page: 122 year: 1993 end-page: 126 ident: CR26 article-title: Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism publication-title: Neuropsychobiology doi: 10.1159/000118966 contributor: fullname: Köhling – volume: 12 start-page: 338 year: 2010 ident: CR20 article-title: Varenicline-induced grand mal seizure publication-title: Epileptic Disord contributor: fullname: Gelisse – volume: 46 start-page: 991 year: 2006 end-page: 998 ident: CR37 article-title: Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers publication-title: J Clin Pharmacol doi: 10.1177/0091270006290669 contributor: fullname: Burstein – volume: 56 start-page: 254 year: 2009 end-page: 263 ident: CR35 article-title: The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2008.08.025 contributor: fullname: Olpe – volume: 92 start-page: 337 year: 2013 end-page: 344 ident: CR29 article-title: Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons publication-title: Life Sci doi: 10.1016/j.lfs.2012.12.013 contributor: fullname: Winzer-Serhan – volume: 11 start-page: 452 year: 2001 ident: 1845_CR27 publication-title: Hippocampus doi: 10.1002/hipo.1060 contributor: fullname: V André – volume: 341 start-page: c6549 year: 2010 ident: 1845_CR17 publication-title: BMJ doi: 10.1136/bmj.c6549 contributor: fullname: K Fagerstrom – volume: 51 start-page: 527 year: 2011 ident: 1845_CR39 publication-title: J Clin Pharmacol doi: 10.1177/0091270010372388 contributor: fullname: H Kikkawa – volume: 4 start-page: 369 year: 2004 ident: 1845_CR14 publication-title: Curr Top Med Chem doi: 10.2174/1568026043451447 contributor: fullname: MW Decker – volume: 52 start-page: 1256 year: 2007 ident: 1845_CR33 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2007.01.006 contributor: fullname: YS Mineur – ident: 1845_CR19 – volume: 27 start-page: 122 year: 1993 ident: 1845_CR26 publication-title: Neuropsychobiology doi: 10.1159/000118966 contributor: fullname: EJ Speckmann – volume: 10 start-page: 383 year: 2009 ident: 1845_CR4 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2635 contributor: fullname: M Sarter – volume: 41 start-page: 1063 year: 2000 ident: 1845_CR13 publication-title: Epilepsia doi: 10.1111/j.1528-1157.2000.tb00300.x contributor: fullname: JA Dani – volume: 14 start-page: 299 year: 2012 ident: 1845_CR22 publication-title: Nicotine Tob Res doi: 10.1093/ntr/ntr213 contributor: fullname: ME Levin – volume: 67 start-page: 338 year: 2013 ident: 1845_CR12 publication-title: Synapse doi: 10.1002/syn.21655 contributor: fullname: P Aracri – volume: 57 start-page: 269 year: 2010 ident: 1845_CR25 publication-title: Neurochem Int doi: 10.1016/j.neuint.2010.06.005 contributor: fullname: H Ween – volume: 12 start-page: 117 year: 1996 ident: 1845_CR24 publication-title: Mol Neurobiol doi: 10.1007/BF02740649 contributor: fullname: MM Rathouz – volume: 46 start-page: 991 year: 2006 ident: 1845_CR37 publication-title: J Clin Pharmacol doi: 10.1177/0091270006290669 contributor: fullname: HM Faessel – volume: 34 start-page: 121 year: 2006 ident: 1845_CR38 publication-title: Drug Metab Dispos doi: 10.1124/dmd.105.006767 contributor: fullname: RS Obach – volume: 65 start-page: 195 year: 2013 ident: 1845_CR31 publication-title: Pharmacol Rep doi: 10.1016/S1734-1140(13)70978-2 contributor: fullname: P Tutka – volume: 78 start-page: 703 year: 2009 ident: 1845_CR6 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2009.05.024 contributor: fullname: C Gotti – volume: 363 start-page: 321 year: 1995 ident: 1845_CR7 publication-title: J Comp Neurol doi: 10.1002/cne.903630212 contributor: fullname: KG Bina – volume: 14 start-page: 922 year: 2004 ident: 1845_CR15 publication-title: Cereb Cortex doi: 10.1093/cercor/bhh052 contributor: fullname: JW Dalley – volume: 145 start-page: 109 year: 2004 ident: 1845_CR5 publication-title: Prog Brain Res doi: 10.1016/S0079-6123(03)45007-3 contributor: fullname: M Alkondon – volume: 92 start-page: 337 year: 2013 ident: 1845_CR29 publication-title: Life Sci doi: 10.1016/j.lfs.2012.12.013 contributor: fullname: DW DuBois – volume: 5 start-page: 537 year: 2006 ident: 1845_CR1 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2088 contributor: fullname: R Niaura – volume: 70 start-page: 801 year: 2006 ident: 1845_CR3 publication-title: Mol Pharmacol doi: 10.1124/mol.106.025130 contributor: fullname: KB Mihalak – volume: 12 start-page: 338 year: 2010 ident: 1845_CR20 publication-title: Epileptic Disord doi: 10.1684/epd.2010.0339 contributor: fullname: A Serafini – volume: 13 start-page: 2680 year: 1993 ident: 1845_CR10 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.13-06-02680.1993 contributor: fullname: C Léna – volume: 92 start-page: 215 year: 1998 ident: 1845_CR8 publication-title: J Physiol Paris doi: 10.1016/S0928-4257(98)80013-2 contributor: fullname: L Descarries – volume: 72 start-page: 1317 year: 1994 ident: 1845_CR32 publication-title: J Neurophysiol doi: 10.1152/jn.1994.72.3.1317 contributor: fullname: N Hussy – volume: 96 start-page: 257 year: 2011 ident: 1845_CR28 publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2011.06.006 contributor: fullname: M Sitges – volume: 57 start-page: 60 year: 2009 ident: 1845_CR21 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.04.006 contributor: fullname: K Spiller – volume: 16 start-page: CD006103 year: 2008 ident: 1845_CR2 publication-title: Cochrane Database Syst Rev contributor: fullname: K Cahill – volume: 231 start-page: 1975 year: 2014 ident: 1845_CR16 publication-title: Psychopharmacology doi: 10.1007/s00213-013-3340-1 contributor: fullname: D Braida – volume: 24 start-page: 1509 year: 1986 ident: 1845_CR30 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(86)90476-4 contributor: fullname: DB Beleslin – volume: 115 start-page: 137 year: 2002 ident: 1845_CR11 publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00371-8 contributor: fullname: PJ Zhu – volume: 67 start-page: 469 year: 2013 ident: 1845_CR36 publication-title: Int J Clin Pract doi: 10.1111/ijcp.12121 contributor: fullname: C Wang – volume: 33 start-page: 289 year: 2010 ident: 1845_CR18 publication-title: Drug Saf doi: 10.2165/11319180-000000000-00000 contributor: fullname: S Tonstad – volume: 24 start-page: 11244 year: 2004 ident: 1845_CR9 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3009-04.2004 contributor: fullname: IW Jones – volume: 56 start-page: 254 year: 2009 ident: 1845_CR35 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2008.08.025 contributor: fullname: D Feuerbach – volume: 347 start-page: 424 year: 2013 ident: 1845_CR34 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.113.206904 contributor: fullname: C Peng – volume: 3 start-page: 102 year: 2002 ident: 1845_CR23 publication-title: Nat Rev Neurosci doi: 10.1038/nrn731 contributor: fullname: A Karlin |
SSID | ssj0001413 |
Score | 2.1106882 |
Snippet | Varenicline is a new drug for smoking cessation, and its effect on epilepsy is not clear. The aim of this study was to investigate whether different doses of... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1807 |
SubjectTerms | Animals Benzazepines - administration & dosage Benzazepines - toxicity Brain - drug effects Dose-Response Relationship, Drug Electroencephalography Epilepsy - chemically induced Male Medicine Medicine & Public Health Neurology Neuroradiology Neurosciences Neurosurgery Nicotinic Agonists - administration & dosage Nicotinic Agonists - toxicity Original Article Psychiatry Quinoxalines - administration & dosage Quinoxalines - toxicity Rats Rats, Wistar Seizures - chemically induced Varenicline |
Title | Single dose varenicline may trigger epileptic activity |
URI | https://link.springer.com/article/10.1007/s10072-014-1845-y https://www.ncbi.nlm.nih.gov/pubmed/24906297 https://www.proquest.com/docview/1619168643 https://search.proquest.com/docview/1627987114 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgkxAX3o_CQEHiBApq2mZZjhNsDARcNiRuVZKmEgK6iW1I-_c4XTuGBgc49dDIiRzX_pyvdgBOpWEqZKpO08DXNAoTQxUPjWuvHbCE8dTmddydrnh4aly1XJucYHZ0kb1clIxk7qjnat184f4iiCgmJZxOlqGKoYejbVebrdvO3cz_sii_FBnjtGMtRVRymT8J-R6NFiDmAj2aR532-n_WuwFrBcYkzalRbMKSzbZg5b5g0beh3kVBr5Yk_aElH64a7NkVSFrypiZkhOk6zkLsAP0F-hNDXOmDu2FiBx7brd5lhxb3J1DDIzaiOgyZDR3TpvxUS4tIzQoWCSOUitKE88RgsPa1ZFIh8EvRB6eBltIawSXH8btQyfqZ3QfChA5ZqhjCB5QWKK0RJ2A2GRpfY9DXHpyVeowH0zYZ8VdDZKeJGDURO03EEw9qpabj4osZxrgARKoNBEgenMxeo607AkNltj92YwIhMcNjkQd70x2azYZppF8PpPDgvNyPOeG_LeXgT6MPYTXIN9SdwNSgMnof2yNYHibj48II3fOmd93-BP1L1eg |
link.rule.ids | 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT8IwEL8IJOqL3x9T1Jn4pFmyriulj0YgGIEXMIGnpe26xESBCJjw33sdG2LQB31ec22u17vf7de7AtwITSQlsuIlga-8kMbak4xq2147IDFhiUnruJtd3ulXa3XbJofmtTDpbfeckkw99Uqxm8_tNYLQw6yEefMClGyz86AIpfv-YFBbOmASpq8iY6C2tCUPczLzJyHfw9EaxlzjR9Ow09j914L3YCdDme79wiz2YcMMD2CznfHoh1DpoqBX48ajiXE_bD3Yiy2RNO6bnLtTTNhxFteM0WOgR9GuLX6wb0wcwXOj3ntoetkLCp5mIZl6ilJiqOXapJ8oYRCrGU5CrrmUYRIzFmsM174SREiEfgl64SRQQhjNmWA4_hiKw9HQnIJLuKIkkQQBBEoLpFKIFDCfpNpXGPaVA7e5IqPxolFG9NUS2WoiQk1EVhPR3IFyruooOzOTCBeAWLWKEMmB6-VntHZLYcihGc3smIALzPFI6MDJYouWs2Ei6VcCwR24y_djRfhvSzn70-gr2Gr22q2o9dh5OoftIN1c-z-mDMXp-8xcQGESzy4zi_wEdw3YjA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED_cBsMXvz-qUyv4pJQ1bbosTzLc5oY6hE3wrSRpCoJ2w23C_nsvXTsn0wfxOeESLsnd7_LLXQAuuCLCJ6LmxJ4rHepHyhGBr0x5bY9EJIh1msfd6bPec73ZMmVyrvNcmPS1e05JznMaTJWmZFIdRXF1KfHNZeZJAXUwQgmcWQFK5laMFqHU6A5u2wtjTGj6QzI6bUNhMpoTmz8J-e6aVvDmCleauqD25r8nvwUbGfq0G_Ptsg1rOtmB8kPGr-9CrY9CX7UdDcfa_jB5Yi8mdVLbb2JmTzCQxxFtPUJLgpZG2SYpwvw9sQdP7dbgpuNkPys4KqBk4kjfJ9o3HJxwY8k1YjjNCGWKCUHjKAgihW7clZxwgZAwRusce5JzrVjAA-y_D8VkmOhDsAmTPokFQWCB0jwhJSIIjDN95UqEA9KCy1yp4WheQCP8KpVsNBGiJkKjiXBmQSVXe5idpXGIE0AMW0foZMH5ohlPgaE2RKKHU9PHYxxjP0ItOJgv12I0DDDdmseZBVf52iwJ_20qR3_qfQblx2Y7vO_27o5h3UvX1lzTVKA4eZ_qEyiMo-lptjk_Abm-4SM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single+dose+varenicline+may+trigger+epileptic+activity&rft.jtitle=Neurological+sciences&rft.au=Erken%2C+Haydar+Ali&rft.au=Erken%2C+G%C3%BClten&rft.au=%C5%9Eim%C5%9Fek%2C+Hasan&rft.au=Korkut%2C+O%C4%9Fuzhan&rft.date=2014-11-01&rft.pub=Springer+Milan&rft.issn=1590-1874&rft.eissn=1590-3478&rft.volume=35&rft.issue=11&rft.spage=1807&rft.epage=1812&rft_id=info:doi/10.1007%2Fs10072-014-1845-y&rft.externalDocID=10_1007_s10072_014_1845_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1590-1874&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1590-1874&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1590-1874&client=summon |